Literature DB >> 22052478

Could the use of bone morphogenetic proteins in fracture healing do more harm than good to our patients?

Domagoj Delimar, Tomislav Smoljanovic, Ivan Bojanic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22052478      PMCID： PMC3291766          DOI： 10.1007/s00264-011-1397-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  7 in total

Review 1.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.

Authors:  Eugene J Carragee; Eric L Hurwitz; Bradley K Weiner
Journal:  Spine J       Date:  2011-06       Impact factor: 4.166

2.  Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.

Authors:  Ben B Pradhan; Hyun W Bae; Edgar G Dawson; Vikas V Patel; Rick B Delamarter
Journal:  Spine (Phila Pa 1976)       Date:  2006-05-01       Impact factor: 3.468

3.  Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results.

Authors:  M Laursen; K Høy; E S Hansen; J Gelineck; F B Christensen; C E Bünger
Journal:  Eur Spine J       Date:  1999       Impact factor: 3.134

4.  Mixing bone graft with OP-1 does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases.

Authors:  Johan Kärrholm; Patrick Hourigan; John Timperley; Reza Razaznejad
Journal:  Acta Orthop       Date:  2006-02       Impact factor: 3.717

5.  Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report.

Authors:  Sreevathsa Boraiah; Omesh Paul; David Hawkes; Matthew Wickham; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2009-08-20       Impact factor: 4.176

6.  Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

Authors:  David A Wong; Anant Kumar; Sanjay Jatana; Gary Ghiselli; Katherine Wong
Journal:  Spine J       Date:  2007-11-26       Impact factor: 4.166

Review 7.  Use and efficacy of bone morphogenetic proteins in fracture healing.

Authors:  Suzanne N Lissenberg-Thunnissen; David J J de Gorter; Cornelis F M Sier; Inger B Schipper
Journal:  Int Orthop       Date:  2011-06-23       Impact factor: 3.075
  7 in total
  4 in total

1.  Bone morphogenetic protein and orthopaedic surgery: can we legitimate its off-label use?

Authors:  Aurélien Courvoisier; Frederic Sailhan; Olivier Laffenêtre; Laurent Obert
Journal:  Int Orthop       Date:  2014-09-30       Impact factor: 3.075

2.  Heterotopic Ossification around the Knee after Internal Fixation of a Complex Tibial Plateau Fracture Combined with the Use of Demineralized Bone Matrix (DBM): A Case Report.

Authors:  Sjoerd P F T Nota; Peter Kloen
Journal:  Arch Bone Jt Surg       Date:  2014-10-15

Review 3.  Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair.

Authors:  Sonia Scarfì
Journal:  World J Stem Cells       Date:  2016-01-26       Impact factor: 5.326

4.  BMP-non-responsive Sca1+ CD73+ CD44+ mouse bone marrow derived osteoprogenitor cells respond to combination of VEGF and BMP-6 to display enhanced osteoblastic differentiation and ectopic bone formation.

Authors:  Vedavathi Madhu; Ching-Ju Li; Abhijit S Dighe; Gary Balian; Quanjun Cui
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.